Boston Scientific Scimed, Inc.

Cardiac Pacemakers, Inc.

University of Massachusetts

Boston Scientific Neuromodulation Corporation

Boston Scientific Corporation

Mark W Boden

Sandra Nagale

Frederick H Strickler

Timothy Paul Harrah

Joseph T Delaney, Jr

Marlene C Schwarz

Gerald Fredrickson

Peter G Edelman

Arthur J Foster

Bryan Allen Clark

Joel T Eggert

Devon N Arnholt

Allan Charles Shuros

G Shantanu Reddy

Claude O Clerc

Shibaji Shome

David R Wulfman

Rudolf Faust

Robert E Richard

George Wilfred Duval

Mohan Krishnan

Charles A Gibson

Kimberly DeGraaf

Ding Sheng He

Jeffrey E Stahmann

Barry Weitzner

Anne Margaret Pianca

Isaac Ostrovsky

John Michael Barker

Aiden Flanagan

Jianmin Li

Peter J Pereira

Peter L Dayton

Jeffrey S Lindquist

James P Rohl

Patrick T Mather

Wendy Naimark

James M Goddard

Thomas Jones

Kyle Harish Srivastava

James Weldon

William George Orinski

Edward Holman Overstreet

Jamie Li

Paul James Miller

Elizabeth Mary Annoni

Mary M Byron

Steven L Kangas

Janusz Kuzma

Shrojalkumar Desai

Andrew Dolan

David Shreeve

Mark Kringle

Amedeo Chiavetta

Christopher Macomber

Danilo Decio

Daniel J Cooke

Patrick Willoughby

Kasyap Venkata Seethamraju

Jonathan Zoll

Jan D Seppala

Lynne E Swanson

Crystal Marie Anderson-Cunanan

Dennis Werner

Michael Eppihimer

Martin Phelan

Umaprasana Ojha

Thomas A Wrobel

Michael C Smith

Michael C Peterson

Deanna Cavallaro

Yitzhak Mendelson

Thomas J Herbst

David J Lehse

Glenn R Gaudette

John Benco

Tatyana Dyndikova

Lan Pham

Aditya Vasudeo Pandit

Stephen Earl DeRoche

Tomoya Higashihara

Shrojalkmar Desai

John Wesley Sheets, Jr

Emma Boutcher

David Ernest Wechter

Eric Michael Petersen

Michael C Larson

Megan Chrobak

Brent Palmisano

Elizabeth M Albrecht

Shaina Brito

Todd Robida

Kolbein K Kolste

Courtney Sikes

John Murphy

Steven Diamond

Jeri'Ann Hiller

Sanda Nagale

Andrew Dolen

Janusz A Kuzman

A stent having an inner surface and an outer surface, at least a portion of the outer surface of the stent comprising a dissolvable adhesive polymer or a degradable adhesive polymer disposed on at least a portion of the outer surface of the stent, the adhesive is activated by exposure to an aqueous environment, the dissolvable adhesive polymer dissolves over time in an aqueous environment, the dissolvable adhesive polymer or the degradable adhesive polymer has a surface tack of about 2 psi to about 14 psi.

Dissolvable or degradable adhesive polymer to prevent stent migration

Medical devices and method for manufacturing medical devices are discloses. An example medical device may include a medical device body formed from one or more multi-melting point polymeric filaments. Each of the filaments may include a polymeric blend comprising a first block polymer and a second polymer. The polymeric blend may have a first melting point and a second melting point less than the first melting point. The medical device body may be heat set at a temperature within 10° C. of the second melting point.

Medical devices formed from polymer filaments

A medical device may include a plurality of links reciprocally movable between a loose configuration having a first rigidity and a compact configuration having a second rigidity greater than the first rigidity, wherein application of a force to a distalmost link of the plurality of links when the plurality of links are in the loose configuration causes the plurality of links to change orientation relative to one another, and application of the force to the distalmost link when the plurality of links are in the compact configuration does not cause the plurality of links to change orientation relative to one another.

Tissue deflecting devices and related methods of use

The present disclosure relates generally to controlled extension medical stents, and more particularly to controlled extension devices positioned in the body to stent the ureter and facilitate drainage from the kidney to the bladder.

Controlled extension stent

Described herein are injectable in vivo crosslinking materials for use as soft tissue filler comprising (a) a reactive multi-arm polymer that comprises a plurality of hydrophilic polymeric arms, at least a portion of the hydrophilic polymeric arms comprising one or more reactive end groups and (b) a multifunctional compound that comprises functional groups that are reactive with the reactive end groups of the reactive multi-arm polymer. Also described herein are systems and methods that are based on such materials.

Injectable in vivo crosslinking materials for use as soft tissue fillers

Various embodiments are generally directed to a flexible elongate member (e.g., endoscopic accessory tool) positionable into and/or through selected anatomies, such as by generating images to position components of a flexible elongate member or to localize anatomic features, for instance. Some embodiments are directed to generating images with a plurality of imaging techniques to localize anatomic features and/or components of a flexible elongate member for one or more of inspection, orientation, and/or facilitating access to body passageways or lumens.

Devices, systems, and methods for imaging within a body lumen

In one aspect, the present disclosure is directed to methods of treating various conditions including bladder conditions in a patient, comprising: positioning at least one ablative element of an ablative device on or over an adventitial surface of the bladder; and using the ablative device to denervate bladder nerve fibers. Other aspects of the present disclosure pertain, for example, to devices and kits for of treating bladder conditions.

Bladder treatment by ablative denervation

In some aspects, the present invention provides surgical procedures that comprise applying compositions into and/or onto tissue, including supporting tissues (e.g., ligaments, connective tissue, muscles, etc.) for pelvic organs, among other tissues. In other aspects, the present disclosure pertains to compositions that are useful for performing such procedures. In still other aspects, the present disclosure pertains to kits that are useful for performing such procedures.

Methods, compositions and kits for surgical repair

An example of a system for monitoring and treating a medical condition of a patient may include signal inputs to receive patient condition signals indicative of a state of inflammatory bowel disease (IBD), a signal processing circuit configured to process the patient condition signals and generate patient condition parameters indicative of the state of IBD using the processed patient condition signals, and a medical condition analyzer configured to analyze the patient condition parameters and determine the medical condition including the state of IBD using an outcome of the analysis. The patient condition parameters may include one or more physiological marker parameters each representative of a physiological marker of IBD and one or more quality of life parameters each being measure of quality of life of the patient.

Method and apparatus for monitoring state of inflammatory bowel disease

In some aspects, the present invention provides surgical procedures that comprise applying compositions into and/or onto pelvic tissue to provide support to the pelvic tissue. The injectable hydrogel composition comprises a polysaccharide. In embodiments, the polysaccharide comprises one or more of a glycosaminoglycan, chitosan, hyaluronic acid, dextran, alginic acid and hydroxyethyl starch. In other aspects, the present disclosure pertains to kits that are useful for performing such procedures.

Methods and kits for providing support to pelvic tissue

A prosthetic heart valve leaflet includes a plurality of electrospun fibers at least partially embedded in a polymer matrix. The plurality of fibers includes a first polyisobutylene urethane copolymer having a first predetermined weight average percentage of hard segment portions and the polymer matrix includes a second polyisobutylene urethane copolymer having a second predetermined weight average percentage of the hard segment portions, wherein the first predetermined weight average percentage of the hard segment portions is greater than the second predetermined weight average percentage of the hard segment portions.

Prosthetic heart valves having fiber reinforced leaflets

Growing community of inventors

Harrisville, RI, United States of America

Mark W Boden